By Chris Hutching
Friday 27th October 2000
|Text too small?|
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
No comments yet
NZ shares rise; F&P Healthcare helped by weak dollar, Ryman, Arvida fall
NZ dollar heading for weekly drop of 2.5% on uncertainty over new govt
Ardern promises proactive govt, regional support as she names Labour Cabinet members
ComCom right to reject media merger, court hears
Auckland Airport infrastructure spend to come under microscope in ComCom review
SkyCity runs ruler over Darwin after 'tough year'
NZ dollar, stocks drop as 3-way government replaces certainty of 3 terms of National
NZ annual net migration continues to cool in September as more Kiwis eye exit
October 20th Morning Report
Metlifecare buys waterfront land in Auckland's Hobsonville for new $240M village